
|Articles|April 14, 2008
Bendamustine approved by FDA for chronic lymphocytic leukemia
Bendamustine has been approved by the FDA for the treatment of CLL
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage
2
CoronaVac Improves Outcomes of COVID-19 for Patients With Schizophrenia
3
From Policy to Practice: Elevating Pharmacy’s Role in Quality and Patient Safety
4
Reducing HIV Stigma Can Improve Patient Care, Provider Connectivity
5
















































































































